Citation: | WU Peng, FENG Feng, HU Daoqing, JIANG Jiaxing, WANG Zhining. Bioinformatics analysis of long non-coding RNA HAGLROS in gastric cancer[J]. Journal of Clinical Medicine in Practice, 2022, 26(15): 57-64. DOI: 10.7619/jcmp.20220715 |
To analyze the significance of long non-coding RNA HAGLROS in gastric cancer by using bioinformatics methods, predict the target genes, related biological processes and pathways of HAGLROS, and establish HAGLROS-miRNA-mRNA network.
UCSC Xena, UALCAN and GEPIA databases were used to analyze the differential expressions of genes in gastric cancer; the co-expression genes of HAGLROS were analyzed by the Cancer Genome Atlas (TCGA) databasein combination with R language; STRING database and Cytoscape software were used to establish protein-protein interaction network (PPI) and screen key genes; microRNA (miRNA) interacting with HAGLROS were predicted by miRDB, LncBase and RNAhybrid databases; miRNA downstream target gene prediction was performed by using miRDB, miRTarBase, TargetScan database and R language; gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis were analyzed by R language, WebGestalt and Metascape online databases; results were drew by R software.
HAGLROS was highly expressed in gastric cancer, and was related to the overall survival of patients with gastric cancer. There were 301 co-expressed genes of HAGLROS, which may be related to biological processes such as embryonic and organ growth and nerve growth, and signal pathways such as Wnt, Notch and stem cell pluripotency regulation, and its key genes were closely related to embryonic growth and nerve growth. NES, FGF8 and FGF3 might be the three genes most closely related to HAGLROS. HAGLROS-miR-1976-ORAI2 axis might be involved in regulating the occurrence and development of gastric cancer.
HAGLROS is highly expressed in gastric cancer and may be related to the biological processes of embryonic growth and nerve growth and the signal pathways such as Wnt, Notch and stem cell pluripotency regulation, which may promote the occurrence and development of gastric cancer and affect the prognosis of patients with gastric cancer by regulating the key genes such as NES, FGF8, FGF3 and HAGLROS-miR-1976-ORAI2 axis.
[1] |
CAO W, CHEN H D, YU Y W, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020[J]. Chin Med J (Engl), 2021, 134(7): 783-791. doi: 10.1097/CM9.0000000000001474
|
[2] |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi: 10.3322/caac.21660
|
[3] |
SCHMITT A M, CHANG H Y. Long noncoding RNAs in cancer pathways[J]. Cancer Cell, 2016, 29(4): 452-463. doi: 10.1016/j.ccell.2016.03.010
|
[4] |
YUAN L, XU Z Y, RUAN S M, et al. Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance[J]. Mol Cancer, 2020, 19(1): 96. doi: 10.1186/s12943-020-01219-0
|
[5] |
CHEN J F, WU P, XIA R, et al. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy[J]. Mol Cancer, 2018, 17(1): 6. doi: 10.1186/s12943-017-0756-y
|
[6] |
GAI L, HUANG Y Q, ZHAO L L, et al. Long non-coding RNA HAGLROS regulates the proliferation, migration, and apoptosis of esophageal cancer cells via the HAGLROS-miR-206-NOTCH3 axis[J]. J Gastrointest Oncol, 2021, 12(5): 2093-2108. doi: 10.21037/jgo-21-586
|
[7] |
WEI H M, HU J, PU J, et al. Long noncoding RNA HAGLROS promotes cell proliferation, inhibits apoptosis and enhances autophagy via regulating miR-5095/ATG12 axis in hepatocellular carcinoma cells[J]. Int Immunopharmacol, 2019, 73: 72-80. doi: 10.1016/j.intimp.2019.04.049
|
[8] |
JONES C A, HAZLEHURST L A. Role of calcium homeostasis in modulating EMT in cancer[J]. Biomedicines, 2021, 9(9): 1200. doi: 10.3390/biomedicines9091200
|
[9] |
张宁刚, 罗锋. 早期胚胎与肿瘤相关性[J]. 国际肿瘤学杂志, 2007, 34(10): 732-735. doi: 10.3760/cma.j.issn.1673-422X.2007.10.005
|
[10] |
马延磊, 秦环龙. 早期胚胎发育与肿瘤发生的相关性研究进展[J]. 世界华人消化杂志, 2008, 16(12): 1337-1343. doi: 10.3969/j.issn.1009-3079.2008.12.015
|
[11] |
钟艳平, 李啸然, 刘劲松. 肿瘤起源二元论与生命密码[J]. 中华病理学杂志, 2020, 49(12): 1227-1231. doi: 10.3760/cma.j.cn112151-20200714-00555
|
[12] |
夏启俊, 陈凛. 胃癌神经侵袭的细胞与分子机制[J]. 中华胃肠外科杂志, 2015(2): 198-200. doi: 10.3760/cma.j.issn.1671-0274.2015.02.026
|
[13] |
SILVERMAN D A, MARTINEZ V K, DOUGHERTY P M, et al. Cancer-associated neurogenesis and nerve-cancer cross-talk[J]. Cancer Res, 2021, 81(6): 1431-1440. doi: 10.1158/0008-5472.CAN-20-2793
|
[14] |
MAUFFREY P, TCHITCHEK N, BARROCA V, et al. Progenitors from the central nervous system drive neurogenesis in cancer[J]. Nature, 2019, 569(7758): 672-678. doi: 10.1038/s41586-019-1219-y
|
[15] |
AMIT M, TAKAHASHI H, DRAGOMIR M P, et al. Loss of p53 drives neuron reprogramming in head and neck cancer[J]. Nature, 2020, 578(7795): 449-454. doi: 10.1038/s41586-020-1996-3
|
[16] |
ZHAN T, RINDTORFF N, BOUTROS M. Wnt signaling in cancer[J]. Oncogene, 2017, 36(11): 1461-73. doi: 10.1038/onc.2016.304
|
[17] |
NERADIL J, VESELSKA R. Nestin as a marker of cancer stem cells[J]. Cancer Sci, 2015, 106(7): 803-811. doi: 10.1111/cas.12691
|
[18] |
ISHIWATA T, MATSUDA Y, NAITO Z. Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis[J]. World J Gastroenterol, 2011, 17(4): 409-418. doi: 10.3748/wjg.v17.i4.409
|
[19] |
ZHANG J L, TANG P M K, ZHOU Y H, et al. Targeting the oncogenic FGF-FGFR axis in gastric carcinogenesis[J]. Cells, 2019, 8(6): 637. doi: 10.3390/cells8060637
|
[20] |
陆江. 胚胎神经干细胞/祖细胞分化的分子机制及诱导为多巴胺能神经元的研究[D]. 南宁: 广西大学, 2010.
|
[21] |
TATETSU H, KONG N R, CHONG G, et al. SALL4, the missing link between stem cells, development and cancer[J]. Gene, 2016, 584(2): 111-119. doi: 10.1016/j.gene.2016.02.019
|
[22] |
PAREKH A B. Store-operated CRAC channels: function in health and disease[J]. Nat Rev Drug Discov, 2010, 9(5): 399-410. doi: 10.1038/nrd3136
|
[23] |
MOCCIA F, ZUCCOLO E, POLETTO V, et al. Targeting stim and orai proteins as an alternative approach in anticancer therapy[J]. Curr Med Chem, 2016, 23(30): 3450-3480. doi: 10.2174/0929867323666160607111220
|
[24] |
WU S Y, CHEN M, HUANG J, et al. ORAI2 promotes gastric cancer tumorigenicity and metastasis through PI3K/Akt signaling and MAPK-dependent focal adhesion disassembly[J]. Cancer Res, 2021, 81(4): 986-1000. doi: 10.1158/0008-5472.CAN-20-0049
|